Sewanti Limaye, Co- Chair at Asia Pacific Coalition against Lung Cancer, shared a post on LinkedIn:
“Honoured to be hosting Prof. Dr. Alison Zhang from Macquarie University, Sydney Australia for an insightful session on “Setting a New Cancer Care Course with Enfortumab Vedotin in Locally Advanced or metastatic Urothelial Cancers” supported by Sir H. N. Reliance Foundation Hospital and Research Centre and Astellas Pharma, Tarang Gianchandani, Vijay Haribhakti.
Thank you for your support Santoshi Nagaonkar and Urology Oncology! Team Med Onc RFH Dr Pritam Kataria Darshit Shah Niyati Shah!
Date: Saturday, 20th September 2025
Time: 12:00 pm – 2:00 pm
Venue: Sir H. N. Reliance Foundation Hospital and Research Centre, Mumbai
This session will focus on:
– Unlocking Enfortumab Vedotin’s potential for patients with advanced urothelial cancer
– Leveraging real-world evidence for informed decision-making
– Safety considerations and clinical case discussions.
We look forward to engaging discussions, case-based learning, and collaborative knowledge-sharing that will empower us to better support our patients.
Let’s explore how we can make a difference in the lives of those battling complex cancers.”
More Posts Featuring Sewanti Limaye.
